fda bpc 157 category 2 bulk drug substance list has removed certain substances that were placed on the two and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of This just in: The FDA
This just in: The FDA is proposing to move 14 commonly used peptides from Category 2 to Category 1 on the compounding review list If finalized, this shift could significantly change FDA advisers back first four of seven unapproved peptides under review for looser rules Reuters Peptide Therapy in Austin, TX Austin Plastic Surgeon Dr. Chuma FDA Adds Several Peptides to Category 2 Bulks List, Restricting Them From Compounding Restore Health Consulting Is BPC 157 Legal in 2026? FDA Compounding Status Explained
Pay in 4 interest-free payments of $7.24 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9


